Compugen (CGEN +3.1%) announces that it will "significantly" broaden its monoclonal antibody program and will establish preclinical development capabilities in-house instead of using third parties. The firm will take on $8M in funding from Israel-based Baize Investments to help move along its research program.
Are you Bullish or Bearish on ?
Results for ()
Thanks for sharing your thoughts.
From other sites
at Zacks.com (Fri, 9:57AM)
at CNBC.com (Feb 25, 2014)
at CNBC.com (Sep 3, 2013)
at MarketWatch.com (Aug 5, 2013)
at MarketWatch.com (May 19, 2011)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs